Blood glucose is unlikely to be a prognostic biomarker in acute colitis with systemic inflammatory response syndrome in Thoroughbred racehorses

Although hyperglycemia at admission with colic has been reported to have a poor prognosis, there is no report specifically about acute colitis with systemic inflammatory response syndrome (SIRS) in horses. In this study, we measured blood glucose (Glu), insulin (Ins), and cortisol (Cor) levels in 17...

Descripción completa

Detalles Bibliográficos
Autores principales: URAYAMA, Shuntaro, ARIMA, Daisuke, MIZOBE, Fumiaki, SHINZAKI, Yuta, NOMURA, Motoi, MINAMIJIMA, Yohei, KUSANO, Kanichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Equine Science 2018
Materias:
Note
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865065/
https://www.ncbi.nlm.nih.gov/pubmed/29593444
http://dx.doi.org/10.1294/jes.29.15
Descripción
Sumario:Although hyperglycemia at admission with colic has been reported to have a poor prognosis, there is no report specifically about acute colitis with systemic inflammatory response syndrome (SIRS) in horses. In this study, we measured blood glucose (Glu), insulin (Ins), and cortisol (Cor) levels in 17 Thoroughbred racehorses diagnosed as having acute colitis with SIRS, and examined the relationship between time-dependent changes in Glu, Ins, and Cor and prognosis. Glu levels were high in 3 horses at admission, but thereafter no horses had persistently high Glu levels. There was no significant difference in Glu, Ins, and Cor levels within 72 hr between surviving and non-surviving horses. In conclusion, the Glu level is unlikely to be a useful prognostic biomarker in acute colitis with SIRS.

Ejemplares similares